CTOs on the Move

Central Georgia Health Network

www.mycghn.com

 
CGHN has been a trusted partner for Central Georgia independent physicians for over 20 years, with proven success in favorable payouts, dividends and contracting. This commitment to physician independence is at the very heart of CGHN`s identity. CGHN`s ownership structure ensures independent physicians in Central Georgia maintain a strong, controlling governance voice. CGHN is a growing, clinically-integrated network representing nearly 1,000 independent physicians, healthcare professionals and hospital partners across Central Georgia. Our goal is to deliver the best patient care experiences, while enhancing care quality and lowering costs.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.mycghn.com
  • 111 Perimeter Parkway
    Macon, GA USA 31210
  • Phone: 478.832.6134

Executives

Name Title Contact Details
Gabriel Orthous
 Chief Information Officer Profile

Similar Companies

Graham Hospital

Graham Hospital is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. Graham Hospital is based in Canton, IL. You can find more information on Graham Hospital at www.grahamhospital.org

Upper Chesapeake Health

Established as a non-profit organization in 1995, the Upper Chesapeake Health Foundation is dedicated to supporting UCH and its vision to create the healthiest community in Maryland. The funds raised are managed in accordance with donor wishes,

StoneRidge Treatment & Recovery

StoneRidge Treatment & Recovery is a leading addiction treatment center located in Prescott Valley. We specialize in providing world-class brain-focused mental health and addiction services. Our comprehensive approach includes addiction detox services,...

Heartland Health Region

Heartland Health Region is a Rosetown, SK-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Journey Colab

We are pursuing FDA approval of psychedelic therapies to heal individual mental health and strengthen communities. We plan to build a portfolio of plant-identical compounds. Our first compound in development is mescaline.